
A new wireless and wearable device developed by Northwestern Medicine scientists measures specific biomarkers in a person’s sweat and has the potential to improve clinical decision-making for cystic fibrosis, as detailed in a recent study published in the Proceedings of the National Academy of Sciences.

A novel drug may significantly improve outcomes for a subset of patients with high blood pressure, according to findings published in The New England Journal of Medicine.

Northwestern Medicine scientists have discovered how a subset of immune cells are essential for successful organ transplantation acceptance, according to a recent study published in The Journal of Clinical Investigation.

A genetic mismatch may influence kidney transplant success and could inform how donor-recipient compatibility is assessed, according to a study published in Science Translational Medicine.

The new core will provide access to the Glacios-2 Cryo-Transmission Electron Microscope, ancillary equipment for grid preparation and expertise as a shared resource to enhance research throughout the University.

Over a quarter-century of research, Northwestern scientists have been studying individuals over eighty with memory capacity of people at least three decades younger, to identify the biological and behavioral traits associated with “SuperAging.”

A multi-center study has identified critical risk factors that increase the likelihood of death in children with Fontan circulatory failure who are awaiting or have recently undergone heart transplantation, according to findings published in Circulation.

A drug already FDA-approved for asthma was found to nearly eliminate life-threatening allergic reactions to food allergens in mice, according to a new Northwestern Medicine study published in the journal Science.

Northwestern scientists have created a free online tool that calculates a person’s “heart age” based on their risk for cardiovascular disease using routine health data, according to a study published in JAMA Cardiology.

Scientists have implemented a novel gene-editing approach that may be an effective treatment for alternating hemiplegia of childhood (AHC), a rare neurodevelopmental disorder in children, according to a recent study published in Cell.